🔗 Visit the ClinicalTrials.gov page for NCT00734526
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? | Nat Rev Clin Oncol | 2012 | 1.65 |
| 2 | Pathway inhibition: emerging molecular targets for treating glioblastoma. | Neuro Oncol | 2011 | 1.38 |
| 3 | Experimental approaches for the treatment of malignant gliomas. | Pharmacol Ther | 2010 | 1.23 |
| 4 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. | Curr Cancer Drug Targets | 2010 | 1.07 |
| 5 | Unique biology of gliomas: challenges and opportunities. | Trends Neurosci | 2012 | 0.87 |
| 6 | Combining drugs and radiotherapy: from the bench to the bedside. | Curr Opin Neurol | 2009 | 0.81 |
| 7 | Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment. | Front Oncol | 2014 | 0.79 |